Collaborations between our researchers, biotech and pharmaceutical companies have led to the development of drugs that have been approved or are currently being tested in clinical trials for the treatment of blood cancers and other diseases.
Building on this, we continue to focus our efforts on developing improved treatments for people with cancer and to make the basic research discoveries that will lead to future breakthrough cancer therapies.
To contact the division please email our Division Coordinators:
